First Header Logo Second Header Logo

Connection

Steven Feldman to Dermatitis, Atopic

Back to Details
This is a "connection" page, showing publications Steven Feldman has written about Dermatitis, Atopic.
Steven Feldman
Connection Strength
23.418
Dermatitis, Atopic
  1. Ghamrawi R, Bell KA, Balogh EA, Strowd LC, Feldman SR. Current and emerging biologics for the treatment of pediatric atopic dermatitis. Expert Opin Biol Ther. 2020 12; 20(12):1435-1445.
    View in: PubMed
    Score: 0.647
  2. Stein Gold LF, Takiya L, Zang C, Sanders P, Feldman SR. Demographics and Baseline Disease Characteristics of Early Responders to Crisaborole for Atopic Dermatitis. J Drugs Dermatol. 2020 Jun 01; 19(6):619-624.
    View in: PubMed
    Score: 0.627
  3. Bashyam AM, Cuellar-Barboza A, Masicampo EJ, Feldman SR. Framing atopic dermatitis topical medication application site discomfort as a signal of efficacy improves willingness to continue use. J Am Acad Dermatol. 2020 Dec; 83(6):1773-1775.
    View in: PubMed
    Score: 0.620
  4. Mendes JT, Balogh EA, Strowd LC, Feldman SR. An evaluation of baricitinib as a therapeutic option for adult patients with moderate to severe atopic dermatitis. Expert Opin Pharmacother. 2020 Jun; 21(9):1027-1033.
    View in: PubMed
    Score: 0.619
  5. Howell AN, Ghamrawi RI, Strowd LC, Feldman SR. Pharmacological management of atopic dermatitis in the elderly. Expert Opin Pharmacother. 2020 May; 21(7):761-771.
    View in: PubMed
    Score: 0.616
  6. Bashyam AM, Cuellar-Barboza A, Ghamrawi RI, Feldman SR. Placebo tailoring improves patient satisfaction of treatment plans in atopic dermatitis. J Am Acad Dermatol. 2020 Sep; 83(3):944-946.
    View in: PubMed
    Score: 0.613
  7. Cohen SR, Haidari W, Feldman SR. Why aren't they using their medicine? Pediatr Dermatol. 2020 01; 37(1):62-63.
    View in: PubMed
    Score: 0.609
  8. Johnson MC, Pona A, Adler-Neal AL, Kesty C, Cline A, Feldman SR. Assessing the Effect of Clinical Trial Evidence and Anecdote on Caregivers' Willingness to Use Corticosteroids: A Randomized Controlled Trial [Formula: see text]. J Cutan Med Surg. 2020 Jan/Feb; 24(1):17-22.
    View in: PubMed
    Score: 0.593
  9. Cline A, Unrue EL, Collins A, Feldman SR. Adherence to a novel home phototherapy system with integrated features. Dermatol Online J. 2019 Mar 15; 25(3).
    View in: PubMed
    Score: 0.577
  10. Glines KR, Stiff KM, Freeze M, Cline A, Strowd LC, Feldman SR. An update on the topical and oral therapy options for treating pediatric atopic dermatitis. Expert Opin Pharmacother. 2019 04; 20(5):621-629.
    View in: PubMed
    Score: 0.569
  11. Hogue L, Cardwell LA, Roach C, Felix KH, Oussedik E, Richardson I, Feldman SR. Psoriasis and Atopic Dermatitis "Resistant" to Topical Treatment Responds Rapidly to Topical Desoximetasone Spray. J Cutan Med Surg. 2019 Mar/Apr; 23(2):157-163.
    View in: PubMed
    Score: 0.567
  12. Curry ZA, Johnson MC, Unrue EL, Feldman SR. Caregiver willingness to treat atopic dermatitis is not much improved by anchoring. J Dermatolog Treat. 2019 Aug; 30(5):471-474.
    View in: PubMed
    Score: 0.566
  13. Seger EW, Wechter T, Strowd L, Feldman SR. Relative efficacy of systemic treatments for atopic dermatitis. J Am Acad Dermatol. 2019 Feb; 80(2):411-416.e4.
    View in: PubMed
    Score: 0.559
  14. Okwundu N, Cardwell LA, Cline A, Unrue EL, Richardson IM, Feldman SR. Topical corticosteroids for treatment-resistant atopic dermatitis. Cutis. 2018 Sep; 102(3):205-209.
    View in: PubMed
    Score: 0.556
  15. Lewis DJ, Feldman SR. Rapid, successful treatment of atopic dermatitis recalcitrant to topical corticosteroids. Pediatr Dermatol. 2018 Mar; 35(2):278-279.
    View in: PubMed
    Score: 0.531
  16. Alexander T, Maxim E, Cardwell LA, Chawla A, Feldman SR. Prescriptions for atopic dermatitis: oral corticosteroids remain commonplace. J Dermatolog Treat. 2018 May; 29(3):238-240.
    View in: PubMed
    Score: 0.521
  17. Patel NU, D'Ambra V, Feldman SR. Increasing Adherence with Topical Agents for Atopic Dermatitis. Am J Clin Dermatol. 2017 Jun; 18(3):323-332.
    View in: PubMed
    Score: 0.509
  18. Strowd LC, Feldman SR. Dupilumab for atopic dermatitis. Lancet. 2017 06 10; 389(10086):2265-2266.
    View in: PubMed
    Score: 0.507
  19. Saleem MD, Oussedik E, D'Amber V, Feldman SR. Interleukin-31 pathway and its role in atopic dermatitis: a systematic review. J Dermatolog Treat. 2017 Nov; 28(7):591-599.
    View in: PubMed
    Score: 0.501
  20. McGregor SP, Farhangian ME, Huang KE, Feldman SR. Treatment of Atopic Dermatitis in the United States: Analysis of Data from the National Ambulatory Medical Care Survey. J Drugs Dermatol. 2017 Mar 01; 16(3):250-255.
    View in: PubMed
    Score: 0.501
  21. Patel N, Feldman SR. Adherence in Atopic Dermatitis. Adv Exp Med Biol. 2017; 1027:139-159.
    View in: PubMed
    Score: 0.495
  22. Mudigonda T, Kaufman W, Feldman SR. Horrendous, Treatment-resistant Pediatric Atopic Dermatitis Solved With a Change in Vehicle. J Drugs Dermatol. 2016 Jan; 15(1):114-5.
    View in: PubMed
    Score: 0.462
  23. Snyder A, Farhangian M, Feldman SR. A review of patient adherence to topical therapies for treatment of atopic dermatitis. Cutis. 2015 Dec; 96(6):397-401.
    View in: PubMed
    Score: 0.459
  24. McGregor S, Farhangian ME, Feldman SR. Dupilumab for the treatment of atopic dermatitis: A clinical trial review. Expert Opin Biol Ther. 2015; 15(11):1657-60.
    View in: PubMed
    Score: 0.451
  25. Aslam I, Sandoval LF, Feldman SR. What's new in the topical treatment of allergic skin diseases. Curr Opin Allergy Clin Immunol. 2014 Oct; 14(5):436-50.
    View in: PubMed
    Score: 0.423
  26. Savas JA, Huang KE, Tuchayi SM, Feldman SR. Understanding the influence of social media in medicine: lesson learned from Facebook. Dermatol Online J. 2014 Sep 16; 20(9).
    View in: PubMed
    Score: 0.422
  27. Davis SA, Lin HC, Yu CH, Balkrishnan R, Feldman SR. Underuse of early follow-up visits: a missed opportunity to improve patients' adherence. J Drugs Dermatol. 2014 Jul; 13(7):833-6.
    View in: PubMed
    Score: 0.416
  28. Moustafa F, Feldman SR. A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology. Dermatol Online J. 2014 May 16; 20(5):22608.
    View in: PubMed
    Score: 0.413
  29. Sandoval LF, Feldman SR. Are wash outs needed in clinical trials of topical agents? J Dermatolog Treat. 2014 Feb; 25(1):1.
    View in: PubMed
    Score: 0.404
  30. Sandoval LF, Huang K, O'Neill JL, Gustafson CJ, Hix E, Harrison J, Clark A, Buxton OM, Feldman SR. Measure of atopic dermatitis disease severity using actigraphy. J Cutan Med Surg. 2014 Jan-Feb; 18(1):49-55.
    View in: PubMed
    Score: 0.402
  31. Fenerty SD, O'Neill JL, Gustafson CJ, Feldman SR. Maternal adherence factors in the treatment of pediatric atopic dermatitis. JAMA Dermatol. 2013 Feb; 149(2):229-31.
    View in: PubMed
    Score: 0.377
  32. Shah A, Yentzer BA, Feldman SR. Timing of return office visit affects adherence to topical treatment in patients with atopic dermatitis: an analysis of 5 studies. Cutis. 2013 Feb; 91(2):105-7.
    View in: PubMed
    Score: 0.377
  33. Feldman SR. Let's not presuppose that patients take their medications. J Dermatolog Treat. 2012 Oct; 23(5):317.
    View in: PubMed
    Score: 0.369
  34. Dabade TS, Feldman SR. A consideration when interpreting outpatient data. J Am Acad Dermatol. 2011 Jun; 64(6):1180-1.
    View in: PubMed
    Score: 0.336
  35. Sagransky MJ, Yentzer BA, Williams LL, Clark AR, Taylor SL, Feldman SR. A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. Arch Dermatol. 2010 Dec; 146(12):1428-30.
    View in: PubMed
    Score: 0.325
  36. Yentzer BA, Ade RA, Fountain JM, Clark AR, Taylor SL, Borgerding E, Feldman SR. Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis. Cutis. 2010 Oct; 86(4):208-13.
    View in: PubMed
    Score: 0.321
  37. Yentzer BA, Camacho FT, Young T, Fountain JM, Clark AR, Feldman SR. Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance. J Drugs Dermatol. 2010 Apr; 9(4):324-9.
    View in: PubMed
    Score: 0.310
  38. Ntuen E, Taylor SL, Kinney M, O'Neill JL, Krowchuk DP, Feldman SR. Physicians' perceptions of an eczema action plan for atopic dermatitis. J Dermatolog Treat. 2010 Jan; 21(1):28-33.
    View in: PubMed
    Score: 0.305
  39. Wilson R, Camacho F, Clark AR, Young T, Inabinet R, Yentzer BA, Feldman SR. Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis. J Am Acad Dermatol. 2009 Jan; 60(1):166-8.
    View in: PubMed
    Score: 0.284
  40. Feldman SR. Adherence must always be considered: is everolimus really ineffective as a treatment for atopic dermatitis? J Dermatolog Treat. 2009; 20(6):317-8.
    View in: PubMed
    Score: 0.284
  41. Brown KL, Krejci-Manwaring J, Tusa MG, Camacho F, Fleischer AB, Balkrishnan R, Feldman SR. Poor compliance with topical corticosteroids for atopic dermatitis despite severe disease. Dermatol Online J. 2008 Sep 15; 14(9):13.
    View in: PubMed
    Score: 0.279
  42. Krejci-Manwaring J, McCarty MA, Camacho F, Manuel J, Hartle J, Fleischer A, Feldman SR. Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper. J Drugs Dermatol. 2008 Jul; 7(7):643-6.
    View in: PubMed
    Score: 0.275
  43. Chisolm SS, Taylor SL, Balkrishnan R, Feldman SR. Written action plans: potential for improving outcomes in children with atopic dermatitis. J Am Acad Dermatol. 2008 Oct; 59(4):677-83.
    View in: PubMed
    Score: 0.273
  44. Conde JF, Kaur M, Fleischer AB, Tusa MG, Camacho F, Feldman SR. Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis. Cutis. 2008 May; 81(5):435-41.
    View in: PubMed
    Score: 0.271
  45. Krejci-Manwaring J, Tusa MG, Carroll C, Camacho F, Kaur M, Carr D, Fleischer AB, Balkrishnan R, Feldman SR. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007 Feb; 56(2):211-6.
    View in: PubMed
    Score: 0.245
  46. Feldman S, Behnam SM, Behnam SE, Koo JY. Involving the patient: impact of inflammatory skin disease and patient-focused care. J Am Acad Dermatol. 2005 Jul; 53(1 Suppl 1):S78-85.
    View in: PubMed
    Score: 0.223
  47. Freeze ME, Balogh EA, Cline A, Feldman SR, Fleischer AB. Comparing prescribing patterns for topical corticosteroids based on their FDA indication by age. Pediatr Dermatol. 2021 Jan; 38(1):115-118.
    View in: PubMed
    Score: 0.162
  48. Newsom M, Bashyam AM, Balogh EA, Feldman SR, Strowd LC. New and Emerging Systemic Treatments for Atopic Dermatitis. Drugs. 2020 Jul; 80(11):1041-1052.
    View in: PubMed
    Score: 0.158
  49. Simpson E, Bissonnette R, Eichenfield LF, Guttman-Yassky E, King B, Silverberg JI, Beck LA, Bieber T, Reich K, Kabashima K, Seyger M, Siegfried E, Stingl G, Feldman SR, Menter A, van de Kerkhof P, Yosipovitch G, Paul C, Martel P, Dubost-Brama A, Armstrong J, Chavda R, Frey S, Joubert Y, Milutinovic M, Parneix A, Teixeira HD, Lin CY, Sun L, Klekotka P, Nickoloff B, Dutronc Y, Mallbris L, Janes JM, DeLozier AM, Nunes FP, Paller AS. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis. J Am Acad Dermatol. 2020 Sep; 83(3):839-846.
    View in: PubMed
    Score: 0.156
  50. Jackson DG, Cardwell LA, Oussedik E, Feldman SR. Utility of boron in dermatology. J Dermatolog Treat. 2020 Feb; 31(1):2-12.
    View in: PubMed
    Score: 0.150
  51. Visconti MJ, Haidari W, Feldman SR. Transcutaneous electrical nerve stimulation (TENS): a review of applications in dermatology. J Dermatolog Treat. 2020 Dec; 31(8):846-849.
    View in: PubMed
    Score: 0.149
  52. Bray JK, Johnson MC, Masicampo EJ, Feldman SR. Optimizing presentation of expected treatment outcomes. J Am Acad Dermatol. 2020 Aug; 83(2):602-604.
    View in: PubMed
    Score: 0.148
  53. Ramachandran V, Cline A, Feldman SR, Strowd LC. Evaluating crisaborole as a treatment option for atopic dermatitis. Expert Opin Pharmacother. 2019 Jun; 20(9):1057-1063.
    View in: PubMed
    Score: 0.145
  54. Paller A, Jaworski JC, Simpson EL, Boguniewicz M, Russell JJ, Block JK, Tofte S, Dunn JD, Feldman SR, Clark AR, Schwartz G, Eichenfield LF. Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders. Am J Clin Dermatol. 2018 Dec; 19(6):821-838.
    View in: PubMed
    Score: 0.141
  55. Simpson EL, Guttman-Yassky E, Margolis DJ, Feldman SR, Qureshi A, Hata T, Mastey V, Wei W, Eckert L, Chao J, Arnold RJG, Yu T, Vekeman F, Suárez-Fariñas M, Gadkari A. Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis. JAMA Dermatol. 2018 08 01; 154(8):903-912.
    View in: PubMed
    Score: 0.138
  56. He A, Feldman SR, Fleischer AB. Trends in Atopic Dermatitis Management: Comparison of 1990-1997 to 2003-2012. J Drugs Dermatol. 2018 Feb 01; 17(2):135-140.
    View in: PubMed
    Score: 0.133
  57. Edwards T, Patel NU, Blake A, Prabakaran S, Reimer D, Feldman SR, Strowd LC. Insights into future therapeutics for atopic dermatitis. Expert Opin Pharmacother. 2018 02; 19(3):265-278.
    View in: PubMed
    Score: 0.133
  58. He A, Feldman SR, Fleischer AB. An assessment of the use of antihistamines in the management of atopic dermatitis. J Am Acad Dermatol. 2018 Jul; 79(1):92-96.
    View in: PubMed
    Score: 0.133
  59. Shukla S, Feldman SR, Strowd LC. A safety review of the medications used to treat atopic dermatitis. Expert Opin Drug Saf. 2018 02; 17(2):179-183.
    View in: PubMed
    Score: 0.132
  60. Eichenfield LF, Boguniewicz M, Simpson EL, Russell JJ, Block JK, Feldman SR, Clark AR, Tofte S, Dunn JD, Paller AS. Translating Atopic Dermatitis Management Guidelines Into Practice for Primary Care Providers. Pediatrics. 2015 Sep; 136(3):554-65.
    View in: PubMed
    Score: 0.112
  61. Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG, Chamlin SL, Cohen DE, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Eichenfield LF. Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014 Dec; 71(6):1218-33.
    View in: PubMed
    Score: 0.106
  62. Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, Chamlin SL, Cooper KD, Feldman SR, Hanifin JM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Silverman RA, Simpson EL, Tom WL, Williams HC, Elmets CA, Block J, Harrod CG, Begolka WS, Eichenfield LF. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014 Aug; 71(2):327-49.
    View in: PubMed
    Score: 0.103
  63. Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, Bergman JN, Chamlin SL, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Margolis DJ, Silverman RA, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Sidbury R. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014 Jul; 71(1):116-32.
    View in: PubMed
    Score: 0.103
  64. Landis ET, Davis SA, Taheri A, Feldman SR. Top dermatologic diagnoses by age. Dermatol Online J. 2014 Apr 16; 20(4):22368.
    View in: PubMed
    Score: 0.103
  65. Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, Berger TG, Bergman JN, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Silverman RA, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Sidbury R. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014 Feb; 70(2):338-51.
    View in: PubMed
    Score: 0.100
  66. Steele T, Pawaskar M, Balkrishnan R, Fleischer A, Feldman SR. Does cost-effectiveness play a role in clinical trials? Dermatol Ther. 2007 Mar-Apr; 20(2):110-9.
    View in: PubMed
    Score: 0.063
  67. Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB, Manuel JC. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol. 2005 May-Jun; 22(3):192-9.
    View in: PubMed
    Score: 0.055
  68. Housman TS, Norton AB, Feldman SR, Fleischer AB, Simpson EL, Hanifin JM, Antaya RJ. Tacrolimus ointment: utilization patterns in children under age 2 years. Dermatol Online J. 2004 Jul 15; 10(1):2.
    View in: PubMed
    Score: 0.052
  69. Balkrishnan R, Housman TS, Grummer S, Rapp SR, Clarke J, Feldman SR, Fleischer AB. The family impact of atopic dermatitis in children: the role of the parent caregiver. Pediatr Dermatol. 2003 Jan-Feb; 20(1):5-10.
    View in: PubMed
    Score: 0.047
  70. Janumpally SR, Feldman SR, Gupta AK, Fleischer AB. In the United States, blacks and Asian/Pacific Islanders are more likely than whites to seek medical care for atopic dermatitis. Arch Dermatol. 2002 May; 138(5):634-7.
    View in: PubMed
    Score: 0.045
  71. Tan X, Feldman SR, Chang J, Balkrishnan R. Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert Opin Drug Deliv. 2012 Oct; 9(10):1263-71.
    View in: PubMed
    Score: 0.023
  72. Ou HT, Feldman SR, Balkrishnan R. Understanding and improving treatment adherence in pediatric patients. Semin Cutan Med Surg. 2010 Jun; 29(2):137-40.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.